๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for NSCLC, Stage I

Osimertinib Therapy After Resection in High-risk Stage I EGFRm NSCLC (OSTAR) NCT05686434Phase 21 site๐Ÿ“ Tianjin Tianjin Medical University Cancer Institute and Hospital ยท Tests: Osimertinib TGRX-1942 Chinese Phase I for Advanced Solid Tumor And/or Relapsed/Refractory Hematologic Malignancies NCT06484816Phase 11 site๐Ÿ“ Hangzhou Shenzhen TargetRx Co., Ltd. ยท Tests: TGRX-1942 A Study of MT-4561 in Patients With Various Advanced Solid Tumors NCT06943521Phase 1, Phase 26 sites๐Ÿ“ Los Angeles๐Ÿ“ Grand Rapids๐Ÿ“ Columbus Tanabe Pharma America, Inc. ยท Tests: MT-4561 A First-in-Human, JAB-8263 in Adult Patients With Advanced Tumors NCT04686682Phase 1, Phase 21 site๐Ÿ“ Tianjin Jacobio Pharmaceuticals Co., Ltd. ยท Tests: JAB-8263, JAB-8263 Fulzerasib Sequential Sintilimab Plus Platinum-Doublet Neoadjuvant Therapy for Resectable KRAS G12C-Mutant NSCLC NCT07492342Phase 23 sites๐Ÿ“ Beijing๐Ÿ“ Guangzhou๐Ÿ“ Zhejiang Jianxing He ยท Tests: fulzerasib Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV) NCT07154706Phase 333 sites๐Ÿ“ Los Angeles๐Ÿ“ Orange๐Ÿ“ Washington D.C. Nuvation Bio Inc. ยท Tests: Taletrectinib, Placebo Study of JYP0015 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS NCT06895031Phase 21 site๐Ÿ“ Beijing Guangzhou JOYO Pharma Co., Ltd ยท Tests: JYP0015 Quality of Life Intervention to Inform Patient Decision-Making in Early-Stage Lung Cancer NCT05292521NA1 site๐Ÿ“ Buffalo Roswell Park Cancer Institute ยท Tests: Best Practice, Informational Intervention, Questionnaire Administration Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors NCT07261631Phase 19 sites๐Ÿ“ Princeton๐Ÿ“ Montreal๐Ÿ“ Odense C Novartis Pharmaceuticals ยท Tests: 68Ga-NNS309, 177Lu-DFC413 A Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid Tumors NCT06043466Phase 12 sites๐Ÿ“ Hangzhou๐Ÿ“ Hangzhou Chongqing Precision Biotech Co., Ltd ยท Tests: CEA-targeted CAR-T cells Sotorasib in Combination With Trastuzumab Deruxtecan for the Treatment of Locally Advanced and Metastatic Non-small Cell Lung Cancer With a KRAS G12C Mutation NCT07012031Phase 1, Phase 29 sites๐Ÿ“ Sacramento๐Ÿ“ Tampa๐Ÿ“ Tampa National Cancer Institute (NCI) ยท Tests: Biopsy Procedure, Biospecimen Collection, Computed Tomography, Echocardiography Test, Magnetic Resonance Imaging Investigating the Combination of Bexmarilimab and Nivolumab in Solid Tumours, Melanoma and NSCLC NCT07718243Phase 1, Phase 22 sites๐Ÿ“ Manchester๐Ÿ“ Sutton Institute of Cancer Research, United Kingdom ยท Tests: Bexmarilimab 1mg/kg and nivolumab 1mg/kg, Bexmarilimab 3mg/kg and nivolumab 1mg/kg, Recommended Phase II Dose A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014) NCT07513376Phase 3124 sites๐Ÿ“ Sacramento๐Ÿ“ Aurora๐Ÿ“ New Haven Merck Sharp & Dohme LLC ยท Tests: Intismeran, Pembrolizumab coformulated with berahyaluronidase alfa, Placebo A Study Evaluating the Effect of Aumolertinib on the Pharmacokinetics of Midazolam in Patients With NSCLC NCT06926413Phase 11 site๐Ÿ“ Hangzhou Jiangsu Hansoh Pharmaceutical Co., Ltd. ยท Tests: Aumolertinib๏ผ›midazolam JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer NCT02468024Phase 350 sites๐Ÿ“ La Jolla๐Ÿ“ Aurora๐Ÿ“ Colorado Springs University of Texas Southwestern Medical Center ยท Tests: Lung Surgery, Radiation therapy A Study of BL-M09D1 in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer and Other Solid Tumors NCT07056556Phase 11 site๐Ÿ“ Shanghai Sichuan Baili Pharmaceutical Co., Ltd. ยท Tests: BL-M09D1 A Study of EP0031 (Lunbotinib) in Patients With Advanced RET-altered Malignancies NCT05443126Phase 1, Phase 252 sites๐Ÿ“ Los Angeles๐Ÿ“ Stanford๐Ÿ“ Washington D.C. Ellipses Pharma ยท Tests: EP0031, Platinum chemotherapy, Pemetrexed FIH Trial of VERT-002 in Patients With Locally Advanced or Metastatic Solid Tumors With MET Alterations NCT06669117Phase 1, Phase 219 sites๐Ÿ“ Washington D.C.๐Ÿ“ Canton๐Ÿ“ Nashville Pierre Fabre Medicament ยท Tests: VERT-002 A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors NCT07115043Phase 1, Phase 213 sites๐Ÿ“ Grand Rapids๐Ÿ“ St Louis๐Ÿ“ Pittsburgh AstraZeneca ยท Tests: AZD6750, rilvegostomig A Study to Investigate ALE.P02 as a Monotherapy or in Combination With Pembrolizumab in Adult Patients With Selected CLDN1+ Solid Tumors NCT06747585Phase 1, Phase 241 sites๐Ÿ“ Scottsdale๐Ÿ“ Fullerton๐Ÿ“ Los Angeles Alentis Therapeutics AG ยท Tests: ALE.P02, Pembrolizumab A Dose-escalation and Dose-expansion Phase I/Phase II Clinical Study of Dositinib Mesylate Tablets (90-1408) in the Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer With Positive EGFR Mutation NCT07231068Phase 1, Phase 25 sites๐Ÿ“ Beijing๐Ÿ“ Beijing๐Ÿ“ Guangzhou Henan Genuine Biotech Co., Ltd. ยท Tests: Dositinib mesylate tablets A Study to Assess the Efficacy and Safety of WSD0922-FU in Patients With EGFRm+ Advanced Non-small Cell Lung Cancer NCT06631989Phase 1, Phase 212 sites๐Ÿ“ Hefei๐Ÿ“ Beijing๐Ÿ“ Guangzhou Wayshine Biopharm, Inc. ยท Tests: WSD0922-FU A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-8989 in Patients With Advanced Solid Tumors Harboring KRAS G12D Mutations NCT07610798Phase 1, Phase 21 site๐Ÿ“ Guangzhou Shenzhen Ionova Life Sciences Co., Ltd. ยท Tests: INV-8989 Pulmonary Watershed Topographic Map Navigation for Lung Nodule Resection NCT06404164NA1 site๐Ÿ“ Guangzhou Guangdong Provincial People's Hospital ยท Tests: Wedge resection under watershed analysis method Study of Neoadjuvant Cemiplimab and Dupilumab in Early-Stage Non-Small Cell Lung Cancer NCT06743581NA2 sites๐Ÿ“ Montreal๐Ÿ“ Montreal Centre hospitalier de l'Universitรฉ de Montrรฉal (CHUM) ยท Tests: Cemiplimab, Dupilumab Station 4L Lymph Node Dissection Versus No Dissection in Clinical Stage I Solid Nodule-Type Invasive NSCLC NCT07801430NA1 site๐Ÿ“ Shanghai Fudan University ยท Tests: Station 4L Lymph Node Dissection Neoadjuvant Intra-tumor Double Immunotherapy for Lung Cancer. NCT06492421Phase 21 site๐Ÿ“ Guanzhou Second Affiliated Hospital of Guangzhou Medical University ยท Tests: ipilimumab, pembrolizumab, durvalumab, idarubicin, bevacizumab Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001) NCT05579366Phase 1, Phase 266 sites๐Ÿ“ Phoenix๐Ÿ“ Tucson๐Ÿ“ Los Angeles Genmab ยท Tests: Rina-S, Carboplatin, Bevacizumab, Pembrolizumab, Erythromycin A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors NCT07070232Phase 1, Phase 277 sites๐Ÿ“ Phoenix๐Ÿ“ San Francisco๐Ÿ“ Hartford BioNTech SE ยท Tests: BNT326, Pumitamig, Itraconazole, Paroxetine Mediastinal Lymph Node Dissection Versus Spared Mediastinal Lymph Node Dissection in Stage I GGN NSCLC NCT04631770NA1 site๐Ÿ“ Tianjin Tianjin Medical University Cancer Institute and Hospital ยท Tests: Systemic mediastinal lymph node dissection, Spared mediastinal lymph node dissection
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy